Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Boston Scientific Corp (BSX)  
$95.12 0.13 (0.14%) as of 4:30 Thu 4/17


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 1,430,000,000
Market Cap: 136.02(B)
Last Volume: 6,672,965 Avg Vol: 8,025,383
52 Week Range: $67.33 - $106.18
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Medical Instruments & Supplies

Member Indexes:
    S&P COMPOSITE 1500     NYSE COMPOSITE
    S&P 500

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    : 3
Insider 3/6 Months : 3.6
Guru Rank Number :  39
Guru Rank Value     : 15.1
Guru Occurances    : 4

 

            6 Months   1 Year   2 Year  
 
Company Profile   Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 50 50 50
Total Buy Value $0 $4,515 $4,515 $4,515
Total People Bought 0 1 1 1
Total Buy Transactions 0 1 1 1
Total Shares Sold 376,434 627,303 1,422,639 2,314,532
Total Sell Value $38,589,526 $60,202,747 $123,979,289 $173,054,382
Total People Sold 9 11 13 13
Total Sell Transactions 21 33 54 90
End Date 2025-01-19 2024-10-18 2024-04-19 2023-04-20

   
Records found: 2518
  Page 1 of 101  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Mahoney Michael F Chairman, President & CEO   •       •      –    2025-04-01 4 AS $100.01 $16,445,072 D/D (164,442) 1,594,530 -7%     
   Mahoney Michael F Chairman, President & CEO   •       •      –    2025-04-01 4 OE $17.26 $2,183,144 D/D 105,618 1,758,972     -
   Brown Vance R SVP, GC and Corp. Secretary   •       •      –    2025-03-21 4 AS $100.85 $486,702 D/D (4,826) 41,019 -7%     
   Woodworth Emily SVP, Global Controller and CAO   •       •      –    2025-03-04 4 AS $104.63 $50,432 D/D (482) 432 -10%     
   Woodworth Emily SVP, Global Controller and CAO   •       •      –    2025-03-03 4 AS $104.97 $750,465 D/D (7,149) 914 -11%     
   Woodworth Emily SVP, Global Controller and CAO   •       •      –    2025-03-03 4 OE $37.50 $223,088 D/D 5,949 8,063     -
   Woodworth Emily SVP, Global Controller and CAO   •       •      –    2025-03-01 4 D $103.79 $36,845 D/D (355) 2,114     -
   Woodworth Emily SVP, Global Controller and CAO   •       •      –    2025-03-01 4 OE $0.00 $0 D/D 837 2,469     -
   Woodworth Emily SVP, Global Controller and CAO   •       •      –    2025-02-28 4 AS $101.13 $999,872 D/D (9,887) 1,632 -10%     
   Woodworth Emily SVP, Global Controller and CAO   •       •      –    2025-02-28 4 OE $42.16 $304,311 D/D 7,218 11,519     -
   Mirviss Jeffrey B. EVP&Pres, Periph Intervent   •       •      –    2025-02-25 4 AS $104.00 $279,552 D/D (2,688) 25,766 -7%     
   Fitzgerald Joseph Michael EVP & Group Pres, Cardiology   •       •      –    2025-02-25 4 GD $0.00 $0 D/D 340 178,342     -
   Mirviss Jeffrey B. EVP&Pres, Periph Intervent   •       •      –    2025-02-24 4 AS $104.25 $487,369 D/D (4,675) 28,454 -10%     
   Fitzgerald Joseph Michael EVP & Group Pres, Cardiology   •       •      –    2025-02-24 4 GA $0.00 $0 I/I 340 5,234     -
   Fitzgerald Joseph Michael EVP & Group Pres, Cardiology   •       •      –    2025-02-24 4 GD $0.00 $0 D/D 1,700 178,682     -
   Zane Ellen M Director   •       •      –    2025-02-24 4 AS $104.23 $1,416,134 D/D (13,586) 34,944 -10%     
   Brown Vance R SVP, GC and Corp. Secretary   •       •      –    2025-02-21 4 AS $104.64 $504,993 D/D (4,826) 45,845 -10%     
   Fitzgerald Joseph Michael EVP & Group Pres, Cardiology   •       •      –    2025-02-20 4 GD $0.00 $0 D/D 1,000 180,382     -
   Sorenson John Bradley EVP, Global Operations   •       •      –    2025-02-19 4 AS $105.19 $347,443 D/D (3,303) 20,991 -11%     
   Mirviss Jeffrey B. EVP&Pres, Periph Intervent   •       •      –    2025-02-19 4 AS $105.35 $159,079 D/D (1,510) 33,129 -11%     
   Brennan Daniel J. EVP and CFO   •       •      –    2025-02-19 4 AS $105.24 $7,086,111 D/D (67,333) 225,808 -11%     
   Brennan Daniel J. EVP and CFO   •       •      –    2025-02-19 4 OE $17.26 $1,550,275 D/D 60,523 293,141     -
   Sorenson John Bradley EVP, Global Operations   •       •      –    2025-02-18 4 AS $104.41 $277,417 D/D (2,657) 24,294 -11%     
   Brennan Daniel J. EVP and CFO   •       •      –    2025-02-18 4 AS $104.08 $1,833,184 D/D (17,530) 232,618 -11%     
   Brennan Daniel J. EVP and CFO   •       •      –    2025-02-17 4 D $106.11 $235,246 D/D (2,217) 250,148     -
  2518 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 101
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us